RVPH logo

RVPH

Profile

Full Name

Reviva Pharmaceuticals Holdings, Inc.

Ticker Symbol

RVPH

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 18, 2018

Indexes

Not included

Website

http://www.revivapharma.com

Employees

14

Key Details

Price

$0.75(-3.85%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.90(+45.45% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.75
RVPH price is $0.75

30-Day Relative Volume

0.45
RVPH 30-day relative volume is 0.45

Price Performance

Price Most recent change

-3.85%
RVPH price was down -3.85% on Apr 15, 2025

Price YTD change

-58.56%
RVPH price is down -58.56% since January 1st

Price 1-year change

-78.45%
RVPH price is down -78.45% year-on-year

Price 3-year change

-65.6%
RVPH price is down -65.6% over the past 3 years

Price Range

Price All-time high

$15.10
RVPH price is currently -95.03% below its historical high of $15.10

Price 3-year low

$0.49
RVPH price is currently +53.06% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$35.05M
RVPH market capitalization is $35.05 million

Market cap 3-year change

+6.26%
RVPH market capitalization is up +6.26% over the past 3 years

Market cap All-time high

$174.87M
RVPH market capitalization is currently -79.95% below its historical high of $174.87 million

Market cap sector rank

32.98%
RVPH market capitalization is higher than 32.98% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+67.41%
RVPH shares outstanding is up +67.41% year-on-year

Shares Outstanding 3-Year Change

+208.85%
RVPH shares outstanding is up +208.85% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-
RVPH beta value is unknown

200-day SMA

$1.31
RVPH price is currently -42.86% below its 200-day simple moving average

50-day SMA

$1.23
RVPH price is currently -39.24% below its 50-day simple moving average

RSI

-
RVPH 14-day relative strength index value is unknown

Volume

0.45
RVPH 30-day relative volume is 0.45

ATR

-
RVPH average true range value is unknown

10-day Historical Volatility

-
RVPH 10-day historical volatility value is unknown

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
RVPH annual revenue value is unknown

Revenue Analysts estimate

-
RVPH annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
RVPH annual revenue 1-year change is unknown

Revenue Sector rank

-
RVPH annual revenue is unknown

EPS

EPS

-$0.90
RVPH annual earnings per share is -$0.90

EPS Analysts estimate

-$0.69
RVPH annual earnings per share is currently +30.76% higher than the consensus analysts' forecast

EPS 1-year change

+45.45%
RVPH annual earnings per share is up +45.45% year-on-year

EPS Sector rank

58.99%
RVPH annual earnings per share is higher than 58.99% of companies in Healthcare sector

Profit

Gross profit

-
RVPH annual gross profit value is unknown

Gross margin

-
RVPH annual gross profit margin value is unknown

Operating profit

-$30.80M
RVPH annual operating income is -$30.80 million

Operating margin

-
RVPH annual operating profit margin value is unknown

Net income

-$29.92M
RVPH annual net profit is -$29.92 million

Net margin

-
RVPH annual net profit margin value is unknown

Expenses

Total expenses

$30.80M
RVPH annual total expenses is $30.80 million

Operating expenses

$30.80M
RVPH annual total operating expenses is $30.80 million

Cost of goods sold

-
RVPH annual cost of goods sold value is unknown

Selling, general & administrative expenses

$7.89M
RVPH annual SGA is $7.89 million

Depreciation and amortization

-
RVPH annual depreciation & amortization value is unknown

Interest expense

$18.50K
RVPH annual interest expense is $18.50 thousand

Income tax

$19.50K
RVPH annual income tax is $19.50 thousand

EBIT & EBITDA

EBIT

-$29.88M
RVPH annual earnings before interest & taxes is -$29.88 million

EBITDA

-$29.88M
RVPH annual EBITDA is -$29.88 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$15.50M
RVPH annual total assets is $15.50 million

Non current assets

$819.70K
RVPH annual long term assets is $819.70 thousand

Current assets

$14.68M
RVPH annual total current assets is $14.68 million

Cash and cash equivalents

$13.48M
RVPH annual cash & cash equivalents is $13.48 million

Accounts receivable

-
RVPH annual accounts receivable value is unknown

Inventory

-
RVPH annual inventory value is unknown

Liabilities

Total liabilities

$14.69M
RVPH annual total liabilities is $14.69 million

Long term liabilities

$89.00K
RVPH annual total long term liabilities is $89.00 thousand

Current liabilities

$14.60M
RVPH annual total current liabilities is $14.60 million

Accounts payable

$6.28M
RVPH annual accounts payable is $6.28 million

Debt

Total debt

$458.20K
RVPH annual total debt is $458.20 thousand

Total debt 1-year change

+100%
RVPH annual total debt is up +100% year-on-year

Long term debt

-
RVPH annual long term debt value is unknown

Short term debt

$458.20K
RVPH annual short term debt is $458.20 thousand

Equity & Capital

Shareholders equity

$812.60K
RVPH annual stockholders equity is $812.60 thousand

Book value

$812.60K
RVPH annual book value is $812.60 thousand

Retained earnings

-$164.27M
RVPH annual retained earnings is -$164.27 million

Working capital

$81.90K
RVPH annual working capital is $81.90 thousand

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$33.54M
RVPH annual cash flow from operations is -$33.54 million

Cash from operations 1-year change

-18.43%
RVPH annual cash flow from operations is down -18.43% year-on-year

Cash from investing

-
RVPH annual cash flow from investing activities value is unknown

Cash from investing 1-year change

-
RVPH annual cash flow from investing activities 1-year change is unknown

Cash from financing

$23.65M
RVPH annual cash flow from financing activities is $23.65 million

Cash from financing 1-year change

-28.7%
RVPH annual cash flow from financing activities is down -28.7% year-on-year

CAPEX

CAPEX

-
RVPH annual capital expenditures value is unknown

CAPEX 1-year change

-
RVPH annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$33.54M
RVPH annual free cash flow is -$33.54 million

Free cash flow 1-year change

-18.43%
RVPH annual free cash flow is down -18.43% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
RVPH annual gross profit margin value is unknown

Operating margin

-
RVPH annual operating profit margin value is unknown

Net margin

-
RVPH annual net profit margin value is unknown

ROA & ROE

ROA

-192.99%
RVPH annual return on assets is -192.99%

ROE

-3681.86%
RVPH annual return on equity is -3681.86%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
RVPH price to earnings ratio value is unknown

PE ratio Sector rank

-
RVPH price to earnings ratio is unknown

PB Ratio

PB ratio

43.14
RVPH price to book ratio is 43.14

PB ratio Sector rank

98.35%
RVPH price to book ratio is higher than 98.35% of companies in Healthcare sector

PS Ratio

PS ratio

-
RVPH price to sales ratio value is unknown

PS ratio Sector rank

-
RVPH price to sales ratio is unknown

Enterprise value

Enterprise value

$22.04M
RVPH enterprise value is $22.04 million

Enterprise value Sector rank

32.59%
RVPH enterprise value is higher than 32.59% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.74
RVPH EV/EBITDA is -0.74

EV/EBITDA Sector rank

47.43%
RVPH EV/EBITDA is higher than 47.43% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.01
RVPH annual current ratio is 1.01

Quick ratio

-
RVPH annual quick ratio value is unknown

Leverage

Debt to equity

0.56
RVPH annual debt to equity ratio is 0.56

Interest coverage ratio

-1615.18
RVPH annual interest coverage ratio is -1615.18

Risk & Stability

Piotroski F-Score

-
RVPH piotroski f-score value is unknown

Altman Z-Score

-
RVPH altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Apr 1, 25 D. Boral Capital
Buy
Jan 22, 25 HC Wainwright & Co.
Buy
Jan 21, 25 D. Boral Capital
Buy
Jan 10, 25 Roth MKM
Buy
Jan 10, 25 Maxim Group
Buy
Nov 14, 24 D. Boral Capital
Buy
Nov 13, 24 D. Boral Capital
Buy
Sep 23, 24 EF Hutton
Buy
Aug 26, 24 Benchmark
Speculative Buy
Aug 16, 24 Maxim Group
Hold

Institutional Ownership

Similar stocks

ATRA logo
Atara Biotherapeutics (ATRA)
RMTI logo
Rockwell Medical (RMTI)
SCYX logo
SCYNEXIS (SCYX)
MODD logo
Modular Medical (MODD)
KPTI logo
Karyopharm Therapeutics (KPTI)
RBOT logo
Vicarious Surgical (RBOT)
FibroBiologics (FBLG)
XFOR logo
X4 Pharmaceuticals (XFOR)
SCLX logo
Scilex Holding (SCLX)
  • What is the ticker symbol for Reviva Pharmaceuticals Holdings?
  • Does Reviva Pharmaceuticals Holdings pay dividends?
  • What sector is Reviva Pharmaceuticals Holdings in?
  • What industry is Reviva Pharmaceuticals Holdings in?
  • What country is Reviva Pharmaceuticals Holdings based in?
  • When did Reviva Pharmaceuticals Holdings go public?
  • Is Reviva Pharmaceuticals Holdings in the S&P 500?
  • Is Reviva Pharmaceuticals Holdings in the NASDAQ 100?
  • Is Reviva Pharmaceuticals Holdings in the Dow Jones?
  • When was Reviva Pharmaceuticals Holdings's last earnings report?
  • When does Reviva Pharmaceuticals Holdings report earnings?
  • Should I buy Reviva Pharmaceuticals Holdings stock now?

What is the ticker symbol for Reviva Pharmaceuticals Holdings?

The ticker symbol for Reviva Pharmaceuticals Holdings is NASDAQ:RVPH

Does Reviva Pharmaceuticals Holdings pay dividends?

No, Reviva Pharmaceuticals Holdings does not pay dividends

What sector is Reviva Pharmaceuticals Holdings in?

Reviva Pharmaceuticals Holdings is in the Healthcare sector

What industry is Reviva Pharmaceuticals Holdings in?

Reviva Pharmaceuticals Holdings is in the Biotechnology industry

What country is Reviva Pharmaceuticals Holdings based in?

Reviva Pharmaceuticals Holdings is headquartered in United States

When did Reviva Pharmaceuticals Holdings go public?

Reviva Pharmaceuticals Holdings's initial public offering (IPO) was on October 18, 2018

Is Reviva Pharmaceuticals Holdings in the S&P 500?

No, Reviva Pharmaceuticals Holdings is not included in the S&P 500 index

Is Reviva Pharmaceuticals Holdings in the NASDAQ 100?

No, Reviva Pharmaceuticals Holdings is not included in the NASDAQ 100 index

Is Reviva Pharmaceuticals Holdings in the Dow Jones?

No, Reviva Pharmaceuticals Holdings is not included in the Dow Jones index

When was Reviva Pharmaceuticals Holdings's last earnings report?

Reviva Pharmaceuticals Holdings's most recent earnings report was on Apr 15, 2025

When does Reviva Pharmaceuticals Holdings report earnings?

The date for Reviva Pharmaceuticals Holdings's next earnings report has not been announced yet

Should I buy Reviva Pharmaceuticals Holdings stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page